Renalys Pharma Provides Financial Support for Alport Syndrome Registry Study in Japan Renalys Pharma is excited to announce its financial backing for a significant study on Alport Syndrome, initiated by the Japanese Society for Pediatric Nephrology.

Renalys Pharma Provides Financial Support for Alport Syndrome Registry Study in Japan #Japan #Tokyo #Renalys_Pharma #Alport_Syndrome #Pediatric_Nephrology